These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 26908746)

  • 1. World Health Organization's Innovative Direct Disbursement Mechanism for Payment of Grassroots Immunization Personnel and Operations in Nigeria: 2004-2015.
    Yehualashet YG; Wadda A; Agblewonu KB; Zhema T; Ibrahim AA; Corr A; Linkins J; Mkanda P; Vaz RG; Nsubuga P; Ashogbon D
    J Infect Dis; 2016 May; 213 Suppl 3(Suppl 3):S108-15. PubMed ID: 26908746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intensified Local Resource Mobilization for the Polio Eradication Initiative: The Experience of World Health Organization in Nigeria During 2008-2015.
    Yehualashet YG; Horton J; Mkanda P; Vaz RG; Afolabi O; Gashu SG; Banda R; O'Malley H; Nsubuga P
    J Infect Dis; 2016 May; 213 Suppl 3(Suppl 3):S101-7. PubMed ID: 26912380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategic Engagement of Technical Surge Capacity for Intensified Polio Eradication Initiative in Nigeria, 2012-2015.
    Yehualashet YG; Mkanda P; Gasasira A; Erbeto T; Onimisi A; Horton J; Banda R; Tegegn SG; Ahmed H; Afolabi O; Wadda A; Vaz RG; Nsubuga P
    J Infect Dis; 2016 May; 213 Suppl 3(Suppl 3):S116-23. PubMed ID: 26912379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mobile Money and the importance of timely, complete payments to frontline health campaign workers in the fight to eradicate polio: pilot experience from a World Health Organization digital payment platform in Africa.
    Hamani A; Hussein Jama I; Roland MAY; Wanjeri L; Oppon-Kusi AA; Karimi D; Kiconco P; Akpotu OE; Saka M
    BMC Health Serv Res; 2023 Jan; 23(1):16. PubMed ID: 36611190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of Dedicated Mobile Teams and Polio Volunteer Community Mobilizers to Increase Access to Zero-Dose Oral Poliovirus Vaccine and Routine Childhood Immunizations in Settlements at High Risk for Polio Transmission in Northern Nigeria.
    Ongwae KM; Bawa SB; Shuaib F; Braka F; Corkum M; Isa HK
    J Infect Dis; 2017 Jul; 216(suppl_1):S267-S272. PubMed ID: 28838155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Journalists Initiatives on Immunisation Against Polio and Improved Acceptance of the Polio Vaccine in Northern Nigeria 2007-2015.
    Warigon C; Mkanda P; Banda R; Zakari F; Damisa E; Idowu A; Bawa S; Gali E; Tegegne SG; Hammanyero K; Nsubuga P; Korir C; Vaz RG
    J Infect Dis; 2016 May; 213 Suppl 3(Suppl 3):S86-90. PubMed ID: 26721745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The contribution of the polio eradication initiative on the operations and outcomes of non-polio public health programs: a survey of programs in the African region.
    Nsubuga P; Masiira B; Ibrahim L; Ndakala N; Dongmo N
    Pan Afr Med J; 2018; 31():207. PubMed ID: 31447967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polio field census and vaccination of underserved populations--northern Nigeria, 2012-2013.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2013 Aug; 62(33):663-5. PubMed ID: 23965829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nigeria experience on the use of polio assets for the 2017/18 measles vaccination campaign follow-up.
    Oteri AJ; Adamu U; Dieng B; Bawa S; Terna N; Nsubuga P; Owoaje ET; Kassogue M; Jean Baptiste AE; Braka F; Shuaib F
    Vaccine; 2021 Nov; 39 Suppl 3():C3-C11. PubMed ID: 33962837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Providing information for decision-making in the Nigerian Polio Eradication Program, 2016-2020.
    Erbeto T; Bammeke P; Aregay A; Kamran Z; Ibrahim A; Usifoh N; Adamu U; Omotayo B; Braka F; Damisa E; Kazadi W; Shuaib F
    Pan Afr Med J; 2023; 45(Suppl 2):11. PubMed ID: 38370106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress toward poliomyelitis eradication--Nigeria, 2005-2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Mar; 56(12):278-81. PubMed ID: 17392680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lessons learned in the implementation of supplementary immunization activity (SIA) field guidelines for injectable vaccines - Experiences from Tanzania.
    Mohamed N; Simba D; Mphuru A; Lyimo D; Kyesi F
    Vaccine; 2020 Nov; 38(49):7741-7746. PubMed ID: 33164797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Updating the evidence base on the operational costs of supplementary immunization activities for current and future accelerated disease control, elimination and eradication efforts.
    Gandhi G; Lydon P
    BMC Public Health; 2014 Jan; 14():67. PubMed ID: 24450832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An evaluation of community perspectives and contributing factors to missed children during an oral polio vaccination campaign--Katsina State, Nigeria.
    Michael CA; Ashenafi S; Ogbuanu IU; Ohuabunwo C; Sule A; Corkum M; Mackay S; Storms AD; Achari P; Biya O; Nguku P; Newberry D; Bwaka A; Mahoney F;
    J Infect Dis; 2014 Nov; 210 Suppl 1():S131-5. PubMed ID: 25316827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. National Stop Transmission of Polio Program support for polio supplemental immunization activities in Nigeria 2012-2016: deployment of management support team.
    Edukugho AA; Waziri NE; Bolu O; Gidado SO; Okeke LA; Uba BV; Idris JM; Michael CA; Adegoke JO; Bammeke P; Adamu US; Nguku PM; Biya O; Ohuanbunwo CJ; Vertefeuille J; Damisa E; Wiesen E
    Pan Afr Med J; 2021; 40(Suppl 1):14. PubMed ID: 36157558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. After polio: Imagining, planning, and delivering a world beyond eradication.
    Taylor S
    Health Place; 2018 Nov; 54():29-36. PubMed ID: 30240932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress toward poliomyelitis eradication--Nigeria, January 2004-July 2005.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2005 Sep; 54(35):873-7. PubMed ID: 16151372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of unmet needs to address noncompliant households during polio supplemental immunization activities in Kaduna state, 2014-2016.
    Iyal HA; Shuaib F; Dauda M; Suleiman A; Braka F; Tegegne SG; Nsubuga P; Nomhwange T; Yehualashet YG; Ishaku S; Warigon C; Zakari F; Umeh G; Samaila L; Abdullahi B; Hammanyero K; Dogo P; Adamu D; Vaz RG; Alemu W
    BMC Public Health; 2018 Dec; 18(Suppl 4):1309. PubMed ID: 30541500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demand Creation for Polio Vaccine in Persistently Poor-Performing Communities of Northern Nigeria: 2013-2014.
    Warigon C; Mkanda P; Muhammed A; Etsano A; Korir C; Bawa S; Gali E; Nsubuga P; Erbeto TB; Gerlong G; Banda R; Yehualashet YG; Vaz RG
    J Infect Dis; 2016 May; 213 Suppl 3(Suppl 3):S79-85. PubMed ID: 26908717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The global polio eradication initiative: lessons learned and prospects for success.
    Aylward B; Tangermann R
    Vaccine; 2011 Dec; 29 Suppl 4():D80-5. PubMed ID: 22486981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.